The two advisory committees have delivered less than enthusiastic support for faster access to new health technologies in their responses to the HTA review.
Advisory committees less than enthusiastic about faster patient access to innovation
December 4, 2024 Latest NewsBioPharmaNews of the DayLatest Video
New Stories
-
ChatGPT would have produced more human responses than these committees
December 5, 2024 - - Latest News -
Anatara provides irritable bowel syndrome clinical trial update
December 4, 2024 - - Australian Biotech -
Digital health company Adherium secures R&D loan facility
December 4, 2024 - - Australian Biotech -
Australians rank access to affordable healthcare as second most important priority
December 4, 2024 - - Latest News -
London Agency bolsters public affairs team with crossbench experience
December 4, 2024 - - Latest News -
Acrux says US FDA approves its nitroglycerin ointment for moderate to severe pain
December 4, 2024 - - Latest News -
Alterity Therapeutics completes last patient visit in ATH434-201 trial in multiple system atrophy
December 4, 2024 - - Australian Biotech